SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Manulife Financial Corporation (MFC.TO) trades at a trailing P/E of 17.0, forward P/E of 11.4. Trailing earnings yield is 5.88%, forward earnings yield 8.74%. PEG 2.10.
Criteria proven by this page:
- VALUE (85/100, Pass) — P/E is below market average (17.0); earnings yield beats bond yields (5.88%).
- Forward P/E 11.4 (down from trailing 17.0) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 2.10 — above 2.0 suggests expensive relative to earnings growth.
- Trailing Earnings Yield 5.88% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 8.74% as earnings recover.
Overall SharesGrow Score: 72/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
85/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — MFC.TO
Valuation Multiples
P/E (TTM)17.0
Forward P/E11.4
PEG Ratio2.10
Forward PEG0.24
P/B Ratio0.00
P/S Ratio1.68
EV/EBITDA0.0
Per Share Data
EPS (TTM)$3.07
Forward EPS (Est.)$4.56
Book Value / Share$0.00
Revenue / Share$31.04
FCF / Share$0.00
Yields & Fair Value
Earnings Yield5.88%
Forward Earnings Yield8.74%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.41 |
$51.69B |
$2.99B |
5.8% |
| 2017 |
$0.98 |
$56.65B |
$2.07B |
3.7% |
| 2018 |
$2.33 |
$37.26B |
$4.67B |
12.5% |
| 2019 |
$2.77 |
$77.82B |
$5.27B |
6.8% |
| 2020 |
$2.93 |
$77.12B |
$5.33B |
6.9% |
| 2021 |
$3.54 |
$59.84B |
$6.66B |
11.1% |
| 2022 |
$-1.10 |
$23.62B |
$-2.1B |
-8.9% |
| 2023 |
$2.61 |
$42.31B |
$5.46B |
12.9% |
| 2024 |
$2.84 |
$45.58B |
$5.63B |
12.4% |
| 2025 |
$3.07 |
$53.01B |
$5.78B |
10.9% |
